speb/financial-data huggingface dataset:
Financial ratios for CBI.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -49930.069930069934
Operating income: -621500.6993006993
Net income: -851985.3146853148
Capital expenditures: 7763.636363636364
Operating cash flow: -479434.26573426573
Depreciation & amortization: 49930.069930069934
Net tangible assets: 1742862.237762238
Owner earnings: -809818.8811188812
Return on net tangible assets (%): -46.46488193803858
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 36876500
Book value: 1742862.2377622377
P/B ratio: 1.4796213767803386
Market cap (USD): 2578776.223776224
Debt to equity: 0.5444873455889818
Current ratio: 0.22689021269471013
Quick ratio: 0.22689021269471013
Interest coverage ratio: -2.317085634134768
Free cash flow (dilution-adjusted): -736388.8111888112
Buyback yield (%): 0
Retained earnings: -11776249.65034965
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.940074938671188
Rule of 40 score: 0
Financial ratios for CBI.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 1405.5944055944055
Operating income: -128999.3006993007
Net income: -115827.27272727274
Capital expenditures: 3922.3776223776226
Operating cash flow: -33851.74825174826
Depreciation & amortization: -1405.5944055944055
Net tangible assets: 1742862.237762238
Owner earnings: -121155.24475524476
Return on net tangible assets (%): -6.951510115383705
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 36876500
Book value: 1742862.2377622377
P/B ratio: 1.4796213767803386
Market cap (USD): 2578776.223776224
Debt to equity: 0.5444873455889818
Current ratio: 0.22689021269471013
Quick ratio: 0.22689021269471013
Interest coverage ratio: -2.7177753222836096
Free cash flow (dilution-adjusted): -3534.2657342657344
Buyback yield (%): 0
Retained earnings: -11776249.65034965
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.629513588653828
Rule of 40 score: 0
Financial ratios for CBI.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -4027.2727272727275
Operating income: -120197.9020979021
Net income: -175265.03496503498
Capital expenditures: 8168.531468531469
Operating cash flow: -150746.85314685316
Depreciation & amortization: 4027.2727272727275
Net tangible assets: 1822262.937062937
Owner earnings: -179406.2937062937
Return on net tangible assets (%): -9.845247360156204
Buffett classification: The Gruesome
Stock price: 0.13986013986013987
Shares outstanding: 36876500
Book value: 1822262.937062937
P/B ratio: 2.8303009091899876
Market cap (USD): 5157552.447552448
Debt to equity: 0.5508216940743776
Current ratio: 0.1654604434366339
Quick ratio: 0.1654604434366339
Interest coverage ratio: -2.3596040854428644
Free cash flow (dilution-adjusted): -160019.58041958042
Buyback yield (%): 0
Retained earnings: -11951514.685314685
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.863282296014177
Rule of 40 score: 0
Financial ratios for CBI.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -4220.43795620438
Operating income: -159805.83941605838
Net income: -184013.13868613137
Capital expenditures: 127.73722627737226
Operating cash flow: -77655.47445255474
Depreciation & amortization: 4220.43795620438
Net tangible assets: 1799625.5474452553
Owner earnings: -179920.43795620438
Return on net tangible assets (%): -9.99765969157412
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
Shares outstanding: 36876500
Book value: 1799625.5474452553
P/B ratio: 2.0939919780554512
Market cap (USD): 3768401.4598540147
Debt to equity: 0.5748324773158406
Current ratio: 0.07399474177268744
Quick ratio: 0.07399474177268744
Interest coverage ratio: -2.956490034030141
Free cash flow (dilution-adjusted): -77527.73722627737
Buyback yield (%): 0
Retained earnings: -12658951.824817518
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.854038731007407
Rule of 40 score: 0
Financial ratios for CBI.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -4228.057553956834
Operating income: -186872.66187050362
Net income: -203338.1294964029
Capital expenditures: 34257.553956834534
Operating cash flow: -6635.971223021583
Depreciation & amortization: 4228.057553956834
Net tangible assets: 1710788.4892086333
Owner earnings: -233367.6258992806
Return on net tangible assets (%): -13.640939681984326
Buffett classification: The Gruesome
Stock price: 0.1366906474820144
Shares outstanding: 36876500
Book value: 1710788.489208633
P/B ratio: 2.9464031899128513
Market cap (USD): 5040672.661870504
Debt to equity: 0.6191271978590376
Current ratio: 0.0592115236882336
Quick ratio: 0.0592115236882336
Interest coverage ratio: -7.087781052172015
Free cash flow (dilution-adjusted): -40893.525179856115
Buyback yield (%): 0
Retained earnings: -12680146.76258993
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.56261702336013
Rule of 40 score: 0
Financial ratios for CHG.DE — annual report dated 2021-12-31
Total revenue: 32562772.727272727
Gross profit: 13932022.727272727
Operating income: -1333818.1818181819
Net income: -1332852.2727272727
Capital expenditures: 1955579.5454545454
Operating cash flow: 3266352.272727273
Depreciation & amortization: 9664795.454545455
Net tangible assets: -11091181.818181818
Owner earnings: 6376363.636363637
Buffett classification: The Gruesome
Stock price: 15.306818181818182
Shares outstanding: 23842152
Book value: 47538386.36363636
P/B ratio: 7.676900998188545
Market cap (USD): 364947485.72727275
Debt to equity: 1.2757214385121307
Current ratio: 13.53662307755572
Quick ratio: 12.565079365079367
Interest coverage ratio: -0.525144063853395
COGS to revenue (%): 57.21487588308456
SG&A to revenue (%): 8.922696163075235
Free cash flow (dilution-adjusted): 1308500
Buyback yield (%): 0.03008527496131465
Retained earnings: -9456784.090909092
Inventory turnover: 13.878828409379498
Receivables turnover: 15.517922224207865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1470057468529316
FCF margin (%): 4.018392447594228
Rule of 40 score: 4.018392447594228
Financial ratios for CHG.DE — annual report dated 2022-12-31
Total revenue: 44752446.80851064
Gross profit: 19512276.59574468
Operating income: -3391276.595744681
Net income: -6260670.212765958
Capital expenditures: 1819404.255319149
Operating cash flow: 6056202.127659575
Depreciation & amortization: 8499265.95744681
Net tangible assets: 24609095.74468085
Owner earnings: 419191.4893617027
Buffett classification: The Gruesome
Stock price: 14.787234042553193
Shares outstanding: 23842152
Book value: 98062734.0425532
P/B ratio: 3.595244260160425
Market cap (USD): 352559481.7021277
Debt to equity: 0.6950904311471477
Current ratio: 11.851441453424327
Quick ratio: 11.039503974953192
Interest coverage ratio: -1.2125246285744715
COGS to revenue (%): 56.399531227342855
SG&A to revenue (%): 9.312268674243414
Free cash flow (dilution-adjusted): 3907255.3191489363
Buyback yield (%): 0.027491965737794163
Retained earnings: -15113840.425531916
Inventory turnover: 9.96591744410234
Receivables turnover: 10.734877192982456
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9162950906885843
FCF margin (%): 8.730819425064123
Revenue growth (%): 37.434386141904106
Rule of 40 score: 46.165205566968226
Financial ratios for CHG.DE — annual report dated 2023-12-31
Total revenue: 78629200
Gross profit: 31215911.111111112
Operating income: -5682022.222222222
Net income: -4537877.777777778
Capital expenditures: 2450511.111111111
Operating cash flow: 8185388.888888889
Depreciation & amortization: 13832166.666666666
Net tangible assets: 7769200
Owner earnings: 6843777.777777777
Buffett classification: The Gruesome
Stock price: 20.333333333333332
Shares outstanding: 23842152
Book value: 137865977.77777776
P/B ratio: 3.5163891179984943
Market cap (USD): 484790424
Debt to equity: 0.5851755545522552
Current ratio: 20.196374208297858
Quick ratio: 19.04078067955163
Interest coverage ratio: -1.2107957343637534
COGS to revenue (%): 60.29984902413974
SG&A to revenue (%): 6.423695014066021
Free cash flow (dilution-adjusted): 4234900
Buyback yield (%): 0
Retained earnings: -20323444.444444444
Inventory turnover: 10.767861919301522
Receivables turnover: 9.193339188002433
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.319014058735338
FCF margin (%): 5.3859126126171954
Revenue growth (%): 75.69810280193879
Rule of 40 score: 81.08401541455598
Financial ratios for CHG.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 18139520.833333336
Buffett classification: The Gruesome
Stock price: 25.625000000000004
Shares outstanding: 23842152
Book value: 234367406.25
P/B ratio: 2.6068264131757872
Market cap (USD): 610955145.0000001
Debt to equity: 0.33954509014980977
Current ratio: 18.338976610656083
Quick ratio: 17.372782945288577
Buyback yield (%): 0
Retained earnings: -31035385.416666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHG.DE — annual report dated 2024-12-31
Total revenue: 115284864.58333334
Gross profit: 48980708.333333336
Operating income: -11003125
Net income: -11947166.666666668
Capital expenditures: 3633739.5833333335
Operating cash flow: 12080166.666666668
Depreciation & amortization: 21191250
Net tangible assets: 18139520.833333336
Owner earnings: 5610343.749999998
Buffett classification: The Gruesome
Stock price: 25.625000000000004
Shares outstanding: 23842152
Book value: 234367406.25
P/B ratio: 2.6068264131757872
Market cap (USD): 610955145.0000001
Debt to equity: 0.33954509014980977
Current ratio: 18.740821804574768
Quick ratio: 17.774628139207262
Interest coverage ratio: -1.9587009490326097
COGS to revenue (%): 57.513322750248996
SG&A to revenue (%): 8.817063384747943
Free cash flow (dilution-adjusted): 7388729.166666667
Buyback yield (%): 0
Retained earnings: -31035385.416666668
Inventory turnover: 14.638698771905617
Receivables turnover: 10.701277692688512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.024567545969318
FCF margin (%): 6.409105994417633
Revenue growth (%): 46.618386786757775
Rule of 40 score: 53.02749278117541
Financial ratios for CISO — annual report dated 2022-12-31
Total revenue: 46549617
Gross profit: 2725321
Operating income: -33138142
Net income: -33775182
Capital expenditures: 512247
Operating cash flow: -10681007
Depreciation & amortization: 3319391
Net tangible assets: -8694155
Owner earnings: -30968038
Buffett classification: The Gruesome
Stock price: 38.25
Shares outstanding: 45313337
Book value: 76445091
P/B ratio: 22.67294233778857
Market cap (USD): 1733235140.25
Debt to equity: 0.1940421393441732
Current ratio: 0.6202890970027665
Quick ratio: 0.6197806327728136
Interest coverage ratio: -48.6666470853447
COGS to revenue (%): 94.14534173288686
SG&A to revenue (%): 77.04351896171347
Free cash flow (dilution-adjusted): -28590749
Buyback yield (%): 0
Retained earnings: -77787604
Inventory turnover: 3712.979412013895
Receivables turnover: 5.680584395995759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.76845790234942
FCF margin (%): -61.419944658191284
Rule of 40 score: -61.419944658191284
Financial ratios for CISO — annual report dated 2023-12-31
Total revenue: 33941139
Gross profit: 2579842
Operating income: -27030481
Net income: -80231083
Capital expenditures: 190588
Operating cash flow: -5920112
Depreciation & amortization: 3371288
Net tangible assets: -7307679
Owner earnings: -77050383
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 45313337
Book value: 16139451
P/B ratio: 4.2956483222384705
Market cap (USD): 69329405.61
Debt to equity: 0.606986941501294
Current ratio: 0.8834053425129287
Quick ratio: 0.8760503627776803
Interest coverage ratio: -11.925705018104425
COGS to revenue (%): 92.3990706381421
SG&A to revenue (%): 87.24021606935466
Free cash flow (dilution-adjusted): -18336908
Buyback yield (%): 0
Retained earnings: -158018687
Inventory turnover: 143.27423363333182
Receivables turnover: 11.32177032654906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -123.45732923844123
FCF margin (%): -54.02561180990419
Revenue growth (%): -27.086104704148262
Rule of 40 score: -81.11171651405246
Financial ratios for CISO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7
Shares outstanding: 45313337
Market cap (USD): 31719335.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CISO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.47
Shares outstanding: 45313337
Market cap (USD): 157237279.39000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CISO — annual report dated 2024-12-31
Total revenue: 30750695
Gross profit: 4507645
Operating income: -14589635
Net income: -24243919
Capital expenditures: 83095
Operating cash flow: -3841706
Depreciation & amortization: 2705872
Net tangible assets: -20553700
Owner earnings: -21621142
Buffett classification: The Gruesome
Stock price: 3.47
Shares outstanding: 45313337
Book value: 1149064
P/B ratio: 136.83944444347748
Market cap (USD): 157237279.39000002
Debt to equity: 10.71973449694708
Current ratio: 0.13949031255330707
Quick ratio: 0.13949031255330707
Interest coverage ratio: -4.070573343020368
COGS to revenue (%): 85.34132317985008
SG&A to revenue (%): 62.1035719680482
Free cash flow (dilution-adjusted): -12939272
Buyback yield (%): 0
Retained earnings: -182262606
Receivables turnover: 15.248676742301699
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -858.8154995646951
FCF margin (%): -42.07798230251381
Revenue growth (%): -9.399932041172807
Rule of 40 score: -51.47791434368662
Financial ratios for CISO — quarterly report dated 2025-03-31
Total revenue: 7162322
Gross profit: 1781602
Operating income: -1709745
Net income: -5379604
Capital expenditures: 0
Operating cash flow: -2953508
Depreciation & amortization: 353931
Net tangible assets: -14490229
Owner earnings: -5025673
Buffett classification: The Gruesome
Stock price: 0.44
Shares outstanding: 45313337
Book value: 6979365
P/B ratio: 2.8566880052841483
Market cap (USD): 19937868.28
Debt to equity: 1.595872260585311
Current ratio: 0.24611446253045063
Quick ratio: 0.24611446253045063
Interest coverage ratio: -0.2081787233721314
COGS to revenue (%): 75.12535739108071
SG&A to revenue (%): 48.746021192568556
Free cash flow (dilution-adjusted): -3811960
Buyback yield (%): 0
Retained earnings: -187642210
Receivables turnover: 3.728754421905057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.913495488584562
FCF margin (%): -53.22240468942893
Rule of 40 score: -53.22240468942893
Financial ratios for CISO — quarterly report dated 2025-06-30
Total revenue: 6713587
Gross profit: 1636840
Operating income: -2329387
Net income: -3009921
Capital expenditures: 0
Operating cash flow: -2349824
Depreciation & amortization: 268143
Net tangible assets: -13683781
Owner earnings: -2741778
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 45313337
Book value: 7552643
P/B ratio: 6.899616140998587
Market cap (USD): 52110337.55
Debt to equity: 1.3817656944727825
Current ratio: 0.187754190684721
Quick ratio: 0.187754190684721
Interest coverage ratio: -3.16359979302168
COGS to revenue (%): 75.6189947341116
SG&A to revenue (%): 59.077613800193554
Free cash flow (dilution-adjusted): -3471575
Buyback yield (%): 0
Retained earnings: -190652131
Receivables turnover: 3.7107570487441293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.16616165460982
FCF margin (%): -51.70968961897716
Revenue growth (%): -6.265216783048849
Rule of 40 score: -57.97490640202601
Financial ratios for CISO — quarterly report dated 2025-09-30
Total revenue: 6461798
Gross profit: 1607314
Operating income: -2634007
Net income: 2532428
Capital expenditures: 0
Operating cash flow: -876710
Depreciation & amortization: 301780
Net tangible assets: -4662358
Owner earnings: 2834208
Return on net tangible assets (%): -60.78915432920423
Buffett classification: The Gruesome
Stock price: 1.05
P/E ratio: 4.696974983099223
Shares outstanding: 45313337
Book value: 16342047
P/B ratio: 2.9114470084439237
Market cap (USD): 47579003.85
Debt to equity: 0.155248360257439
Current ratio: 0.35767619963318326
Quick ratio: 0.35767619963318326
Effective tax rate (%): 0
Interest coverage ratio: -20.705486074536406
COGS to revenue (%): 75.12590149057584
SG&A to revenue (%): 65.63685525298068
Free cash flow (dilution-adjusted): -2142222
Buyback yield (%): 0
Retained earnings: -188124684
Receivables turnover: 4.3588640426321295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.757463253771117
FCF margin (%): -33.15210410477084
Revenue growth (%): -3.750439221238959
Rule of 40 score: -36.9025433260098
Financial ratios for CISO — annual report dated 2025-12-31
Total revenue: 26605998
Gross profit: 6819977
Operating income: -8785052
Net income: -8073930
Capital expenditures: 7491
Operating cash flow: -7971902
Depreciation & amortization: 1374114
Net tangible assets: -5961691
Owner earnings: -6707307
Buffett classification: The Gruesome
Stock price: 0.48
Shares outstanding: 45313337
Book value: 14819934
P/B ratio: 1.467644981414897
Market cap (USD): 21750401.759999998
Debt to equity: 0.18234257993321698
Current ratio: 0.42181671383134356
Quick ratio: 0.42181671383134356
Interest coverage ratio: -0.9548145518745448
COGS to revenue (%): 74.36676872636012
SG&A to revenue (%): 58.65229712488139
Free cash flow (dilution-adjusted): -11925964
Buyback yield (%): 0
Retained earnings: -190341517
Receivables turnover: 20.576680739696386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.810710892294416
FCF margin (%): -44.82434374384302
Revenue growth (%): -13.478384797481812
Rule of 40 score: -58.30272854132484
Financial ratios for CISO — quarterly report dated 2025-12-31
Total revenue: 6268291
Gross profit: 1794221
Operating income: -2111913
Net income: -2216833
Capital expenditures: 7491
Operating cash flow: -1791860
Depreciation & amortization: 450260
Net tangible assets: -5961691
Owner earnings: -1774064
Buffett classification: The Gruesome
Stock price: 0.48
Shares outstanding: 45313337
Book value: 14819934
P/B ratio: 1.467644981414897
Market cap (USD): 21750401.759999998
Debt to equity: 0.18234257993321698
Current ratio: 0.42181671383134356
Quick ratio: 0.42181671383134356
Interest coverage ratio: -16.976656136204692
COGS to revenue (%): 71.37623317105093
SG&A to revenue (%): 62.31577315092742
Free cash flow (dilution-adjusted): -2500207
Buyback yield (%): 0
Retained earnings: -190341517
Receivables turnover: 4.847802465087466
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.214816812999876
FCF margin (%): -39.88658152596936
Revenue growth (%): -2.994630906134794
Rule of 40 score: -42.88121243210416
Financial ratios for CL8.AX — annual report dated 2021-06-30
Total revenue: 749500.7518796992
Gross profit: 348126.31578947365
Operating income: -2636266.165413534
Net income: -2523744.3609022554
Capital expenditures: 39022.55639097744
Depreciation & amortization: 126048.87218045112
Net tangible assets: 2098404.5112781953
Owner earnings: -2436718.0451127817
Return on net tangible assets (%): -116.12241738979631
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 268370391
Book value: 2104394.736842105
P/B ratio: 5.753167274357815
Market cap (USD): 12106934.932330826
Debt to equity: 0.1367749911124053
Current ratio: 3.1005169868249665
Quick ratio: 3.1005169868249665
Interest coverage ratio: -134.75149884704075
COGS to revenue (%): 53.55223928509805
R&D to revenue (%): 114.99654908129322
SG&A to revenue (%): 262.15606177947024
Free cash flow (dilution-adjusted): -2110526.3157894737
Buyback yield (%): 1.9661756700027808
Retained earnings: -15753591.729323307
Receivables turnover: 22.60501610050342
Capitalized R&D asset: 861900
ROCI (R&D-adjusted, %): -65.25683842220262
FCF margin (%): -281.5909537777528
Rule of 40 score: -281.5909537777528
Financial ratios for CL8.AX — annual report dated 2022-06-30
Total revenue: 864664.1379310346
Gross profit: 447008.9655172414
Operating income: -2188187.5862068967
Net income: -2074142.0689655172
Capital expenditures: 183073.10344827586
Depreciation & amortization: 238583.4482758621
Net tangible assets: 356720.6896551724
Owner earnings: -2018631.7241379311
Return on net tangible assets (%): -565.8857987994085
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 268370391
Book value: 355138.6206896552
P/B ratio: 15.634714234946625
Market cap (USD): 5552490.848275862
Debt to equity: 1.8862202423143173
Current ratio: 0.8027045836316034
Quick ratio: 0.8027045836316034
Interest coverage ratio: -2673.017691659646
COGS to revenue (%): 48.30258988341497
R&D to revenue (%): 83.62808600987586
SG&A to revenue (%): 190.16002226896148
Free cash flow (dilution-adjusted): -2094084.827586207
Buyback yield (%): 0.8918395671053493
Retained earnings: -16493295.862068966
Receivables turnover: 5.03679078904552
Capitalized R&D asset: 1300575.0689655172
ROCI (R&D-adjusted, %): -95.60680270923034
Rosenberg metric: 0.11472636005078053
FCF margin (%): -242.184766977491
Revenue growth (%): 15.365346300522459
Rule of 40 score: -226.81942067696855
Financial ratios for CL8.AX — annual report dated 2023-06-30
Total revenue: 1391013.9072847683
Gross profit: 542992.7152317881
Operating income: -2083937.7483443709
Net income: -2080943.7086092716
Capital expenditures: 1167841.7218543047
Depreciation & amortization: 112999.33774834438
Net tangible assets: 336921.8543046358
Owner earnings: -3135786.0927152317
Return on net tangible assets (%): -930.7161446048369
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 268370391
Book value: 342198.0132450331
P/B ratio: 10.387479113405933
Market cap (USD): 3554574.715231788
Debt to equity: 8.641575014659807
Current ratio: 1.0934947970035698
Quick ratio: 1.0934947970035698
Interest coverage ratio: -28.391522457007778
COGS to revenue (%): 60.9642497182721
R&D to revenue (%): 50.017686846175856
SG&A to revenue (%): 128.27733926989268
Free cash flow (dilution-adjusted): -2420685.430463576
Buyback yield (%): 5.612709339459135
Retained earnings: -17880611.9205298
Receivables turnover: 13.35582798679952
Capitalized R&D asset: 1464658.3663393469
ROCI (R&D-adjusted, %): -50.04131586268106
Rosenberg metric: 0.1327388674905367
FCF margin (%): -174.0230933556018
Revenue growth (%): 60.87332020189732
Rule of 40 score: -113.14977315370447
Financial ratios for COS.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4135338345864662
Shares outstanding: 181988796
Market cap (USD): 75258524.66165414
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COS.AX — annual report dated 2022-06-30
Total revenue: 33266461.379310347
Gross profit: 12785543.448275862
Operating income: 5409784.137931035
Net income: 3815706.896551724
Capital expenditures: 79411.03448275862
Depreciation & amortization: 269526.8965517242
Net tangible assets: -3641893.103448276
Owner earnings: 4005822.7586206896
Return on net tangible assets (%): -109.99287032416827
Capex to operating income (%): 1.4679150305825193
Buffett classification: The Great
Stock price: 0.3448275862068966
P/E ratio: 16.446430227146415
Shares outstanding: 181988796
Book value: 23777005.51724138
P/B ratio: 2.6393044824704295
Market cap (USD): 62754757.24137931
Debt to equity: 0.27197885595523785
Current ratio: 1.088107650290144
Quick ratio: 1.0805912288500916
Effective tax rate (%): 27.457729920688003
Interest coverage ratio: 18.209010970644357
COGS to revenue (%): 61.56626548735456
SG&A to revenue (%): 12.053204087563058
Free cash flow (dilution-adjusted): 4694913.103448276
Buyback yield (%): 0
Retained earnings: 5341071.724137931
Inventory turnover: 220.82262705877977
Receivables turnover: 5.586075935587604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.465736341230578
FCF margin (%): 14.113052331944804
Rule of 40 score: 14.113052331944804
Financial ratios for COS.AX — annual report dated 2023-06-30
Total revenue: 49736653.642384104
Gross profit: 17754863.57615894
Operating income: 7309731.125827814
Net income: 5288958.278145695
Capital expenditures: 150431.7880794702
Depreciation & amortization: 342035.76158940396
Net tangible assets: -1716131.1258278145
Owner earnings: 5480562.251655629
Return on net tangible assets (%): -319.35568146122614
Capex to operating income (%): 2.0579660932799912
Buffett classification: The Great
Stock price: 0.4701986754966887
P/E ratio: 16.17915784815723
Shares outstanding: 181988796
Book value: 28356239.735099338
P/B ratio: 3.0177093872047314
Market cap (USD): 85570890.83443707
Debt to equity: 0.35155339859790485
Current ratio: 1.2836019949518431
Quick ratio: 1.2796519078343072
Effective tax rate (%): 21.466205054493987
Interest coverage ratio: 11.939728552405697
COGS to revenue (%): 64.3022554275168
SG&A to revenue (%): 11.206221025289661
Free cash flow (dilution-adjusted): 2319230.463576159
Buyback yield (%): 0.029284421551524033
Retained earnings: 8463103.973509934
Inventory turnover: 525.118284129832
Receivables turnover: 4.087196552146563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.80415235223173
FCF margin (%): 4.66302071758157
Revenue growth (%): 49.50990150493489
Rule of 40 score: 54.172922222516455
Financial ratios for COS.AX — annual report dated 2024-06-30
Total revenue: 67955442
Gross profit: 22829854
Operating income: 8917409.333333334
Net income: 5679604.666666667
Capital expenditures: 337735.3333333333
Depreciation & amortization: 1080814
Net tangible assets: -3366196
Owner earnings: 6422683.333333334
Return on net tangible assets (%): -190.79944641765763
Capex to operating income (%): 3.787370532278657
Buffett classification: The Great
Stock price: 0.7999999999999999
P/E ratio: 25.634008939824096
Shares outstanding: 181988796
Book value: 46249478
P/B ratio: 3.1479498384825013
Market cap (USD): 145591036.79999998
Debt to equity: 0.3555557679303249
Current ratio: 1.3763427953875398
Quick ratio: 1.3752409441832865
Effective tax rate (%): 29.168556398765215
Interest coverage ratio: 9.544733779406927
COGS to revenue (%): 66.40467146104355
SG&A to revenue (%): 11.457952109265952
Free cash flow (dilution-adjusted): 3971519.3333333335
Buyback yield (%): 0
Retained earnings: 11330459.333333334
Inventory turnover: 2810.0457489206246
Receivables turnover: 7.156958182839196
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.74887367684126
FCF margin (%): 5.844299170820393
Revenue growth (%): 36.63050692676755
Rule of 40 score: 42.474806097587944
Financial ratios for CPAI.L — annual report dated 2022-04-30
Total revenue: 0
Gross profit: 0
Operating income: -347661.25
Net income: -1409243.75
Capital expenditures: 0
Operating cash flow: -832671.25
Net tangible assets: -2410885
Owner earnings: -1409243.75
Buffett classification: The Gruesome
Stock price: 0.001875
Shares outstanding: 426433063
Book value: -1973385
Market cap (USD): 799561.9931249999
Debt to equity: 0
Current ratio: 0.028889987644039584
Quick ratio: 0.028889987644039584
Interest coverage ratio: -1.1456339873050134
Free cash flow (dilution-adjusted): -832671.25
Buyback yield (%): 0
Retained earnings: -4180635
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAI.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -95020
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 426433063
Book value: -95019.99999999999
Market cap (USD): 0
Debt to equity: 0
Current ratio: 0.454393029950389
Quick ratio: 0.454393029950389
Retained earnings: -4853030.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAI.L — annual report dated 2024-09-30
Total revenue: 0
Operating income: -302488
Net income: 150282.66666666666
Capital expenditures: 0
Operating cash flow: -437761.3333333333
Net tangible assets: -95020
Owner earnings: 150282.66666666666
Return on net tangible assets (%): -158.1589840735284
Buffett classification: The Gruesome
Stock price: 0
P/E ratio: 0
Shares outstanding: 426433063
Book value: -95019.99999999999
Market cap (USD): 0
Debt to equity: 0
Current ratio: 0.454393029950389
Quick ratio: 0.454393029950389
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -437761.3333333333
Retained earnings: -4853030.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAI.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -123814.28571428571
Buffett classification: The Gruesome
Stock price: 0.0005194805194805195
Shares outstanding: 426433063
Book value: -123814.28571428568
Market cap (USD): 221523.6690909091
Debt to equity: 0
Current ratio: 0.5969621130773719
Quick ratio: 0.5969621130773719
Buyback yield (%): 0
Retained earnings: -4904829.87012987
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAI.L — annual report dated 2025-09-30
Total revenue: 0
Operating income: -1069502.7027027027
Net income: -1068282.4324324324
Capital expenditures: 0
Operating cash flow: -754393.2432432432
Net tangible assets: -13218.918918918918
Owner earnings: -1068282.4324324324
Buffett classification: The Gruesome
Stock price: 0.0005405405405405405
Shares outstanding: 426433063
Book value: -13218.918918918906
Market cap (USD): 230504.35837837838
Debt to equity: 0
Current ratio: 0.9489131910715591
Quick ratio: 0.9489131910715591
Free cash flow (dilution-adjusted): -754393.2432432432
Buyback yield (%): 0
Retained earnings: -5986894.594594595
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAI.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -13218.918918918918
Buffett classification: The Gruesome
Stock price: 0.0005405405405405405
Shares outstanding: 426433063
Book value: -13218.918918918906
Market cap (USD): 230504.35837837838
Debt to equity: 0
Current ratio: 0.9489131910715591
Quick ratio: 0.9489131910715591
Buyback yield (%): 0
Retained earnings: -5986894.594594595
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI.V — annual report dated 2021-08-31
Gross profit: -12633.333333333334
Capital expenditures: 0
Depreciation & amortization: 12633.333333333334
Buffett classification: The Gruesome
Stock price: 0.23015873015873015
Shares outstanding: 316681940
Market cap (USD): 72887113.17460316
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI.V — annual report dated 2022-08-31
Total revenue: 0
Gross profit: -12261.832061068702
Operating income: -4293162.595419847
Net income: -3722722.13740458
Capital expenditures: 80984.73282442748
Operating cash flow: -3857996.1832061065
Depreciation & amortization: 12261.832061068702
Net tangible assets: 2156144.2748091603
Owner earnings: -3791445.038167939
Return on net tangible assets (%): -175.84375417101987
Buffett classification: The Gruesome
Stock price: 0.12213740458015267
Shares outstanding: 316681940
Book value: 2156144.2748091603
P/B ratio: 17.93883214630017
Market cap (USD): 38678710.22900763
Debt to equity: 0.004839710693636401
Current ratio: 3.173224336382634
Quick ratio: 3.173224336382634
Interest coverage ratio: -772.0031571722718
Free cash flow (dilution-adjusted): -4340551.908396946
Buyback yield (%): 0
Retained earnings: -8370860.3053435115
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -199.11295573204785
Rule of 40 score: 0
Financial ratios for CRI.V — annual report dated 2023-08-31
Total revenue: 0
Gross profit: 0
Operating income: -2769731.111111111
Net income: -2275974.814814815
Capital expenditures: 102666.66666666666
Operating cash flow: -2724505.925925926
Depreciation & amortization: 0
Net tangible assets: 1591430.3703703703
Owner earnings: -2378641.4814814813
Return on net tangible assets (%): -149.4656332923887
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 316681940
Book value: 1591430.37037037
P/B ratio: 5.896059775715394
Market cap (USD): 9383168.592592591
Debt to equity: 0
Current ratio: 0.48333045877888925
Quick ratio: 0.48333045877888925
Interest coverage ratio: -760.6055736371034
Free cash flow (dilution-adjusted): -2827254.0740740737
Buyback yield (%): 0
Retained earnings: -10398809.629629629
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -174.04035782391895
Rule of 40 score: 0
Financial ratios for CRI.V — annual report dated 2024-08-31
Total revenue: 0
Operating income: -4427554.814814814
Net income: -4388917.037037036
Capital expenditures: 24411.11111111111
Operating cash flow: -3732483.7037037034
Net tangible assets: 1690756.2962962962
Owner earnings: -4413328.148148147
Return on net tangible assets (%): -261.02686459401684
Buffett classification: The Gruesome
Stock price: 0.08148148148148147
Shares outstanding: 316681940
Book value: 1690756.2962962962
P/B ratio: 15.261639827191074
Market cap (USD): 25803713.629629627
Debt to equity: 0.49616191921125813
Current ratio: 0.8352957902541684
Quick ratio: 0.8352957902541684
Interest coverage ratio: -607.7477376715811
Free cash flow (dilution-adjusted): -4641179.259259258
Buyback yield (%): 0
Retained earnings: -14787726.666666666
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -261.8683026355508
Rule of 40 score: 0
Financial ratios for CRI.V — quarterly report dated 2024-11-30
Capital expenditures: 10714.285714285716
Buffett classification: The Gruesome
Stock price: 0.04285714285714286
Shares outstanding: 316681940
Market cap (USD): 13572083.142857144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -381943.05555555556
Net income: -232443.05555555556
Capital expenditures: 69.44444444444444
Operating cash flow: -563072.9166666667
Net tangible assets: 1070153.4722222222
Owner earnings: -232512.5
Return on net tangible assets (%): -21.72702383679392
Buffett classification: The Gruesome
Stock price: 0.020833333333333332
Shares outstanding: 316681940
Book value: 1070153.472222222
P/B ratio: 6.165041358943196
Market cap (USD): 6597540.416666666
Debt to equity: 0.7349023796560853
Current ratio: 0.4679022356921754
Quick ratio: 0.4679022356921754
Free cash flow (dilution-adjusted): -563142.3611111111
Buyback yield (%): 0
Retained earnings: -15174681.25
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.69049351047131
Rule of 40 score: 0
Financial ratios for CRI.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -267665.94202898553
Net income: -157448.5507246377
Capital expenditures: 14492.753623188408
Operating cash flow: -121039.85507246378
Net tangible assets: 973726.0869565218
Owner earnings: -171941.3043478261
Return on net tangible assets (%): -17.658077220180658
Buffett classification: The Gruesome
Stock price: 0.007246376811594204
Shares outstanding: 316681940
Book value: 973726.0869565217
P/B ratio: 2.356716839988629
Market cap (USD): 2294796.666666667
Debt to equity: 0.8427957152489095
Current ratio: 0.28517045396383806
Quick ratio: 0.28517045396383806
Free cash flow (dilution-adjusted): -135532.6086956522
Buyback yield (%): 0
Retained earnings: -15991898.550724639
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.488833421892
Rule of 40 score: 0
Financial ratios for CRI.V — annual report dated 2025-08-31
Total revenue: 0
Operating income: -2252811.6788321165
Net income: -1829289.0510948903
Capital expenditures: 25620.437956204376
Operating cash flow: -2062802.9197080291
Net tangible assets: 1195989.0510948903
Owner earnings: -1854909.4890510947
Return on net tangible assets (%): -155.0941864687627
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 316681940
Book value: 1195989.0510948903
P/B ratio: 13.529245135046889
Market cap (USD): 16180829.05109489
Debt to equity: 0.6911788490117516
Current ratio: 0.4417053519637193
Quick ratio: 0.4417053519637193
Free cash flow (dilution-adjusted): -2088423.3576642333
Buyback yield (%): 0
Retained earnings: -16401136.496350363
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -188.36390490111413
Rule of 40 score: 0
Financial ratios for CRI.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -447870.802919708
Net income: -292508.7591240876
Capital expenditures: 0
Operating cash flow: -355281.7518248175
Net tangible assets: 1195989.0510948903
Owner earnings: -292508.7591240876
Return on net tangible assets (%): -24.457478005865106
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 316681940
Book value: 1195989.0510948903
P/B ratio: 13.529245135046889
Market cap (USD): 16180829.05109489
Debt to equity: 0.6911788490117516
Current ratio: 0.4417053519637193
Quick ratio: 0.4417053519637193
Free cash flow (dilution-adjusted): -355281.7518248175
Buyback yield (%): 0
Retained earnings: -16401136.496350363
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.447734367609506
Rule of 40 score: 0
Financial ratios for CRI.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -2496644.285714286
Net income: -2375802.8571428573
Capital expenditures: 53142.857142857145
Operating cash flow: -1677053.5714285716
Net tangible assets: 4182092.8571428573
Owner earnings: -2428945.7142857146
Return on net tangible assets (%): -58.07966961176309
Buffett classification: The Gruesome
Stock price: 0.20714285714285713
Shares outstanding: 316681940
Book value: 4182092.857142857
P/B ratio: 15.6855440799463
Market cap (USD): 65598401.85714285
Debt to equity: 0
Current ratio: 3.5155819262063646
Quick ratio: 3.5155819262063646
Free cash flow (dilution-adjusted): -2278525.7142857146
Buyback yield (%): 0
Retained earnings: -18425486.42857143
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -59.69844216754087
Rule of 40 score: 0
Financial ratios for CSAN3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 3.498245614035088
Shares outstanding: 3944354440
Market cap (USD): 13798320619.929825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSAN3.SA — annual report dated 2022-12-31
Total revenue: 8938489583.333332
Gross profit: 1660221022.7272727
Operating income: 1127911742.4242423
Net income: 534256628.78787875
Capital expenditures: 856449810.6060606
Operating cash flow: 1888680303.030303
Depreciation & amortization: 570924242.4242424
Net tangible assets: -278177083.3333333
Owner earnings: 248731060.6060604
Return on net tangible assets (%): -89.41464826130611
Capex to operating income (%): 75.93234278821113
Buffett classification: The Gruesome
Stock price: 3.055028462998103
P/E ratio: 22.554919177497602
Shares outstanding: 3944354440
Book value: 9122992234.848486
P/B ratio: 1.3208511826112577
Market cap (USD): 12050115082.352943
Debt to equity: 1.1733460490133993
Current ratio: 1.6190396977177102
Quick ratio: 1.5007314434866779
Effective tax rate (%): -4.463653927713115
Interest coverage ratio: 1.0889836699279267
COGS to revenue (%): 64.74557330746914
SG&A to revenue (%): 6.4293495793271465
Free cash flow (dilution-adjusted): 1011698863.6363636
Buyback yield (%): 0.13295327569721774
Retained earnings: 1793615340.9090908
Inventory turnover: 16.34877176161908
Receivables turnover: 7.798816608136575
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.017723161903314
FCF margin (%): 11.318454356346432
Rule of 40 score: 11.318454356346432
Financial ratios for CSAN3.SA — annual report dated 2023-12-31
Total revenue: 9647923505.15464
Gross profit: 2251257938.14433
Operating income: 1564194639.175258
Net income: 1007163711.3402063
Capital expenditures: 1291407216.4948454
Operating cash flow: 2118854432.9896908
Depreciation & amortization: 693802680.4123712
Net tangible assets: -349480412.37113404
Owner earnings: 409559175.2577319
Return on net tangible assets (%): -117.190881308334
Capex to operating income (%): 82.5605192698881
Buffett classification: The Gruesome
Stock price: 3.8716356107660452
P/E ratio: 15.162483456702692
Shares outstanding: 3944354440
Book value: 10511583505.15464
P/B ratio: 1.4527880698372952
Market cap (USD): 15271103111.387163
Debt to equity: 1.2196745544140013
Current ratio: 1.7705634172824043
Quick ratio: 1.659619940954792
Effective tax rate (%): 5.36643258539573
Interest coverage ratio: 1.345615852076236
COGS to revenue (%): 61.01392171797707
SG&A to revenue (%): 8.288828092253985
Free cash flow (dilution-adjusted): 783663711.3402061
Buyback yield (%): 0.13944941476851427
Retained earnings: 1956781649.4845362
Inventory turnover: 15.925516284248353
Receivables turnover: 8.5504135744063
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.132530851613492
FCF margin (%): 8.122615305993197
Revenue growth (%): 7.936843414172742
Rule of 40 score: 16.05945872016594
Financial ratios for CSAN3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.408839779005525
Shares outstanding: 3944354440
Market cap (USD): 9501317877.569061
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSAN3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3182552504038771
Shares outstanding: 3944354440
Market cap (USD): 5199665949.983845
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSAN3.SA — annual report dated 2024-12-31
Total revenue: 8372787378.640777
Gross profit: 2219204045.3074436
Operating income: 1638434951.4563107
Net income: -1320674110.0323625
Capital expenditures: 1261745469.2556634
Operating cash flow: 2116712944.9838188
Depreciation & amortization: 625984304.2071198
Net tangible assets: -2496281715.210356
Owner earnings: -1956435275.080906
Capex to operating income (%): 77.00918905167217
Buffett classification: The Gruesome
Stock price: 1.3182552504038771
Shares outstanding: 3944354440
Book value: 6375139482.200647
P/B ratio: 0.8156160291866997
Market cap (USD): 5199665949.983845
Debt to equity: 1.8519850901415649
Current ratio: 1.718008607683184
Quick ratio: 1.602286829655207
Interest coverage ratio: 1.344070647837473
COGS to revenue (%): 58.43414246174993
SG&A to revenue (%): 8.544346913968056
Free cash flow (dilution-adjusted): 838327508.0906149
Buyback yield (%): 0.6003466322211086
Retained earnings: -105146440.12944984
Inventory turnover: 14.586322576287868
Receivables turnover: 8.982005724173176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.20857410696911
FCF margin (%): 10.01252593884341
Revenue growth (%): -13.216689848676669
Rule of 40 score: -3.204163909833259
Financial ratios for CSAN3.SA — quarterly report dated 2025-03-31
Total revenue: 1984313368.0555556
Gross profit: 498384722.22222227
Operating income: 398289583.3333334
Net income: -310398437.5
Capital expenditures: 396507812.5
Operating cash flow: 300330555.5555556
Depreciation & amortization: 168037152.7777778
Net tangible assets: -3246306423.611111
Owner earnings: -538869097.2222222
Capex to operating income (%): 99.55264438039741
Buffett classification: The Gruesome
Stock price: 1.2829861111111112
Shares outstanding: 3944354440
Book value: 6036628124.999998
P/B ratio: 0.8383077206398972
Market cap (USD): 5060551963.819445
Debt to equity: 1.9289811462881494
Current ratio: 2.134919046426046
Quick ratio: 1.9795587925958693
Interest coverage ratio: 1.0914021233870865
COGS to revenue (%): 59.423586646829364
SG&A to revenue (%): 8.531218598652888
Free cash flow (dilution-adjusted): -100502951.3888889
Buyback yield (%): 0.11671843831367805
Retained earnings: -423211805.5555556
Inventory turnover: 3.326995527205378
Receivables turnover: 1.7892057605135538
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0063195338033983
FCF margin (%): -5.064872968495522
Rule of 40 score: -5.064872968495522
Financial ratios for CSAN3.SA — quarterly report dated 2025-06-30
Total revenue: 2248567518.248175
Gross profit: 656231204.379562
Operating income: 555282846.7153285
Net income: -103667335.76642334
Capital expenditures: 350734124.08759123
Operating cash flow: 716912226.2773722
Depreciation & amortization: 181079197.08029196
Net tangible assets: -3519486131.386861
Owner earnings: -273322262.77372265
Capex to operating income (%): 63.16314760347689
Buffett classification: The Good
Stock price: 1.251824817518248
Shares outstanding: 3944354440
Book value: 6040951824.817518
P/B ratio: 0.8173613894412153
Market cap (USD): 4937640777.080292
Debt to equity: 2.017130735669827
Current ratio: 1.8267650909770934
Quick ratio: 1.6837362595246592
Effective tax rate (%): 1745.4656046343227
Interest coverage ratio: 1.6194320133388471
COGS to revenue (%): 55.846625791765234
SG&A to revenue (%): 8.936370682064412
Free cash flow (dilution-adjusted): 361807299.27007294
Buyback yield (%): 0
Retained earnings: -498893248.17518246
Inventory turnover: 3.2694124041364225
Receivables turnover: 2.038698736376233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7335095564183995
FCF margin (%): 16.09056861018572
Revenue growth (%): 13.317158189160633
Rule of 40 score: 29.407726799346353
Financial ratios for CSAN3.SA — quarterly report dated 2025-09-30
Total revenue: 2355944924.81203
Gross profit: 700696992.481203
Operating income: 570074060.150376
Net income: -156847556.39097744
Capital expenditures: 393453759.3984962
Operating cash flow: 753937406.0150375
Depreciation & amortization: 188135902.25563908
Net tangible assets: -3867378759.398496
Owner earnings: -362165413.5338346
Capex to operating income (%): 69.01800781721408
Buffett classification: The Good
Stock price: 1.1597744360902256
Shares outstanding: 3944354440
Book value: 6025186278.195488
P/B ratio: 0.7592398367741477
Market cap (USD): 4574561446.390978
Debt to equity: 2.0986812843367932
Current ratio: 1.7955121264360026
Quick ratio: 1.6544467449853821
Interest coverage ratio: 1.606898316642462
COGS to revenue (%): 55.34293465091948
SG&A to revenue (%): 9.094167235070902
Free cash flow (dilution-adjusted): 359271052.6315789
Buyback yield (%): 2.0349047884852913
Retained earnings: -736675563.9097744
Inventory turnover: 3.283879843638228
Receivables turnover: 2.08780554679179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.738045484507352
FCF margin (%): 15.249552264480187
Revenue growth (%): 4.775369460442567
Rule of 40 score: 20.024921724922756
Financial ratios for CSAN3.SA — quarterly report dated 2025-12-31
Total revenue: 2071546167.8832116
Gross profit: 543988868.6131387
Operating income: 416342335.76642334
Net income: -1058943613.1386861
Capital expenditures: 392574999.99999994
Operating cash flow: 612637591.2408758
Depreciation & amortization: 169660766.42335767
Net tangible assets: -3905547080.2919707
Owner earnings: -1281857846.7153285
Capex to operating income (%): 94.29139587194003
Buffett classification: The Gruesome
Stock price: 0.955116696588869
Shares outstanding: 3944354440
Book value: 5658691970.802921
P/B ratio: 0.6657578822714902
Market cap (USD): 3767318782.908438
Debt to equity: 2.2779996550749124
Current ratio: 2.5782520952670556
Quick ratio: 2.4515984820536887
Interest coverage ratio: 1.221867872277642
COGS to revenue (%): 58.43072890739867
SG&A to revenue (%): 10.234439119621587
Free cash flow (dilution-adjusted): 215339963.50364962
Buyback yield (%): 2.3987901794425106
Retained earnings: -1774110401.459854
Inventory turnover: 3.368324008332072
Receivables turnover: 1.909599578787298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9081478396825828
FCF margin (%): 10.39513223708128
Revenue growth (%): -12.071536729641892
Rule of 40 score: -1.6764044925606125